BioAtla (BCAB) Accumulated Expenses (2020 - 2025)

BioAtla's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $37000.0 for Q4 2025.

• On a quarterly basis, Accumulated Expenses fell 98.64% year-over-year to $37000.0 in Q4 2025; TTM through Dec 2025 was $37000.0, a 98.64% decrease from a year earlier, with the FY2025 full-year figure at $37000.0, down 98.64% from the prior year.
• Accumulated Expenses declined to $37000.0 in Q4 2025 per BCAB's latest filing, from $2.4 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $3.8 million in Q4 2023 and bottomed at $37000.0 in Q4 2025.
• The 5-year median for Accumulated Expenses is $2.2 million (2021), against an average of $2.1 million.
• Across the five-year window, Accumulated Expenses increased 29.2% in 2022 and slumped 98.64% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $2.7 million in 2021, then advanced by 29.2% to $3.5 million in 2022, then increased by 9.82% to $3.8 million in 2023, then declined by 28.07% to $2.7 million in 2024, then slumped by 98.64% to $37000.0 in 2025.
• Per Business Quant, the three latest BCAB Accumulated Expenses figures stand at $37000.0 (Q4 2025), $2.4 million (Q3 2025), and $1.6 million (Q2 2025).